期刊文献+

依达拉奉对重型颅脑损伤患者急性期外周血神经元特异性烯醇化酶表达的影响 被引量:2

Influence of edaravone therapy on serum levels of neuron-specific enolase in the patients of severe brain trauma
原文传递
导出
摘要 目的通过研究依达拉奉对重型颅脑损伤患者急性期外周血神经元特异性烯醇化酶(NSE)表达的影响,进一步研究依达拉奉对重型颅脑损伤患者急性期的治疗效果。方法将入选的60例重型颅脑损伤患者随机分为治疗组和对照组,每组各30例。治疗组在基础治疗的同时加用依达拉奉治疗,对照组除不加用依达拉奉外其他治疗方法同治疗组。两组治疗前、治疗后1、3、5、7d清晨7时抽取外周静脉血测NSE水平。结果治疗组和对照组治疗前NSE水平分别为(48.73±30.46)μg/L和(40.86±22.05)μg/L,两组间比较差异无统计学意义(P〉0.05),治疗后3、5、7d,两组NSE水平分别为(34.16±15.08)、(29.86±12.61)、(29.934-14.77)μg/L和(27.42±10.07)、(22.33±8.93)、(21.17±9.67)μg/L,组内和组间比较差异均有统计学意义(P〈0.05或〈0.01)。而且随着治疗时间的延长,NSE水平进行性下降。两组用药期间未见有任何药物不良反应。结论依达拉奉对重型颅脑损伤患者急性期外周血NSE表达的影响非常显著,对重型颅脑损伤患者急性期有较好的治疗效果,且用药安全,不良反应少。 Objective To study the influence of edaravone therapy on serum levels of neuron- specific enolase (NSE) in the patients of severe brain trauma and assess the therapic effect of edaravone . Method Sixty patients of severe brain trauma were randomly assigned into the treatment group (n = 30) and the control group (n = 30). Besides the routine treatment in both groups, edaravone was only used in the treatment group. NSE levels were measured in the two groups before treatment and at 1st, 3rd, 5th,Tth day after treatment. Results NSE levels before treatment in treatment group and control group were (48.73±30.46)μg/L and (40.86±22.05 )μg/L,respectively,there was no statistical significance between two groups. NSE levels after treatment at 3rd, 5th, 7th day in the two groups were (34.16±15.08),(29.86±12.61),(29.93±14.77)μg/L and (27.42±10.07),(22.33±8.93),(21.17±9.67)μg/L, respectively,there were statistical significances between two groups and in the same group (P〈 0.05 or 〈 0.01 ). With the time of therapy extended, NSE levels declined progressively. There were no significant adverse drug reactions during the treatment period. Conclusions The influence of edaravone therapy on serum levels of NSE in the patients of severe brain trauma is significant, edaravone for patients with severe brain trauma has a better curative effect ,medication safety, and fewer adverse drug reactions during acute phase.
出处 《中国医师进修杂志(外科版)》 2009年第2期29-31,共3页 Chinese Journal of Postgraduates of Medicine
基金 基金项目:深圳市科研基金资助项目(200702053)
关键词 颅脑损伤 磷酸丙酮酸水合酶 依达拉奉 Craniocerebral trauma Phosphopyruvate hydratase Edaravone
作者简介 通信作者:赖连枪,Email:b5p138@126.com
  • 相关文献

同被引文献32

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部